Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

HSP90β (human), (recombinant)

 
ALX-201-147-C025 25 µg 194.00 USD
Do you need bulk/larger quantities?
 

Product Specification

Alternative Name:HSP84, Heat shock protein 90β
 
Source:Produced in Sf9 cells.
 
UniProt ID:P08238
 
Concentration:13mg/ml
 
Formulation:Liquid. In 40mM HEPES/KOH, pH 7.5, containing 20mM potassium chloride and 5% glycerol.
 
Purity:≥99%
 
Applications:WB
 
Shipping:Shipped on Dry Ice
 
Short Term Storage:+4°C
 
Long Term Storage:-80°C
 
Handling:For maximum product recovery after thawing, centrifuge the vial before opening the cap. Avoid freeze/thaw cycles.
 

Product Literature References

Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors: C.V. Devarakonda, et al.; BMC Cancer 15, 614 (2015), Application(s): Immunoprecipitation, Abstract; Full Text
The Hsp90 chaperone as a promising drug target: P.W. Piper, et al.; Curr. Opin. Investig. Drugs 2, 1606 (2001), (Review), Abstract;

General Literature References

Heat-shock protein 90, a chaperone for folding and regulation: D. Picard; Cell. Mol. Life Sci. 59, 1640 (2002), (Review), Abstract;

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
HSP90
By biological activity:
HSP90 Recombinant protein
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Related Literature

Catalogs
Heat Shock Proteins & the Cellular Stress Response Catalog
Heat Shock Proteins & the Cellular Stress Response Catalog
Download as PDF

Brochures
Essential Research Tools for Neurodegeneration & Neural Signaling
Essential Research Tools for Neurodegeneration & Neural Signaling
Download as PDF

Technical Posters
Disease-Associated Stress Signaling
Disease-Associated Stress Signaling
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,